111 related articles for article (PubMed ID: 18809262)
1. Can insulin resistance be reversed by insulin therapy?
Zhao L; Sun D; Cao F; Yin T; Wang H
Med Hypotheses; 2009 Jan; 72(1):34-5. PubMed ID: 18809262
[TBL] [Abstract][Full Text] [Related]
2. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
3. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications.
Tousoulis D; Tsarpalis K; Cokkinos D; Stefanadis C
Diabetes Obes Metab; 2008 Sep; 10(10):834-42. PubMed ID: 18034844
[TBL] [Abstract][Full Text] [Related]
5. Metabolic implications of growth hormone therapy.
Perrini S; Carreira MC; Conserva A; Laviola L; Giorgino F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):79-84. PubMed ID: 19020393
[TBL] [Abstract][Full Text] [Related]
6. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
Pfützner A; Schöndorf T; Hanefeld M; Lübben G; Kann PH; Karagiannis E; Wilhelm B; Forst T
Horm Metab Res; 2009 Mar; 41(3):202-6. PubMed ID: 19224430
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.
Groop PH; Forsblom C; Thomas MC
Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):100-10. PubMed ID: 16929378
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
Serfaty L; Capeau J
Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
[TBL] [Abstract][Full Text] [Related]
10. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
11. Trans fat intake lowers total cholesterol and high-density lipoprotein cholesterol levels without changing insulin sensitivity index in Wistar rats.
Huang Z; Wang B; Pace RD; Yoon S
Nutr Res; 2009 Mar; 29(3):206-12. PubMed ID: 19358935
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and steatosis in humans.
Capeau J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
[TBL] [Abstract][Full Text] [Related]
13. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?
Sarafidis PA; Bakris GL
Am J Nephrol; 2007; 27(1):44-54. PubMed ID: 17245074
[TBL] [Abstract][Full Text] [Related]
14. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
Hirabara SM; Curi R; Maechler P
J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II and the development of insulin resistance: implications for diabetes.
Olivares-Reyes JA; Arellano-Plancarte A; Castillo-Hernandez JR
Mol Cell Endocrinol; 2009 Apr; 302(2):128-39. PubMed ID: 19150387
[TBL] [Abstract][Full Text] [Related]
16. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
Ruan H; Pownall HJ
Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
[TBL] [Abstract][Full Text] [Related]
17. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
[TBL] [Abstract][Full Text] [Related]
18. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
19. Neuronal insulin signal transduction mechanisms in diabetes phenotypes.
Reagan LP
Neurobiol Aging; 2005 Dec; 26 Suppl 1():56-9. PubMed ID: 16225964
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
